Application of Transnasal Dexmedetomidine in Elderly Patients Undergoing Painless Colonoscopy
王文华,吴周全,恽惠方,王志萍
DOI: https://doi.org/10.3877/cma.j.issn.1674-0793.2021.05.006
2021-01-01
Abstract:Objective:To observe the safety and effectiveness of transnasal administration of dexmedetomidine (DEX) in elderly patients undergoing painless colonoscopy.Methods:120 elderly patients who underwent painless colonoscopy in Changzhou Second People’ s Hospital from November 2018 to May 2020 were selected as the research objects. They were randomly divided into control group (group C), low-dose DEX (group D1), medium-dose DEX (group D2) and high-dose DEX (group D3), with 30 cases in each group. After routine ECG monitoring, intranasal administration of 1.5 ml saline for the patients in group C, while intranasal administration of 1.0, 1.5 and 2.0 μg/kg DEX respectively for the patients in group D1, D2, D3. Enteroscopy could be performed after 1.5 mg/kg propofol was administrated, and 0.5 mg/kgpropofol was supplement for somatic reaction, such as body movement, eye opening, and coughing. The mean arterial blood pressure (MAP), heart rate (HR) and pulse oxygen saturation (SpO2) before the intranasal administration of DEX (T0), 15 min after intranasal administration of DEX (T1), just the time of the endoscopy (T2), just the time of splenic flexure (T3), and record the BIS value and total amount of propofol medication after withdrawal (T4) were observed. Recovery time, the number of somatic reactions and adverse reactions (vomit, hypotension and bradycardia) were recorded.Results:(1) Comparison within groups: MAP, HR and BIS values in four groups at T1-T4 were lower than those at T0 (all P<0.05); The SpO2 level in group C at T1-T2 was significantly lower than that in the same group at T0 (P<0.05), and no significant difference was found in the SpO2 level in group D1, D2 and D3 at each time point. (2) Comparison among groups: At T0, there were no significant differences in MAP, HR, SpO2 and BIS values among the four groups. At T1-T4, there were statistically significant differences in MAP, HR, SpO2 and BIS values among the four groups (F=5.323-49.369, all P<0.01). (3) Pairwise comparison among groups: at T1-T4, HR in D3 group was significantly lower than that in the other three groups (P<0.05). At T2-T4, MAP in group D1, D2 and D3 was significantly lower than that in group C (P<0.05), and the change range of group D2 was the least; BIS values in group D1, D2 and D3 were lower than those in group C at T1 and T3, and BIS values at T2 and T4 were higher than those in group C (P<0.05), with the most significant change in group D3. During T1-T4, SpO2 in group D2 and D3 was significantly higher than that in group C (P<0.05), and the change range in group D3 was the most significant. There were significant differences in the amount of propofol (F=28.922, P<0.001), time of recovery (H=24.452, P<0.001) and sedation score (Z=113.500, P<0.001) among the four groups. The dosage of propofol, recovery time and sedation score in group D2 and D3 were significantly better than those in group C (P<0.05). The incidence of hypotension in group C was higher than that in the other three groups, and the incidence of bradycardia in group D3 was higher than that in the other three groups (P<0.05). The overall efficacy of group D2 was better than that of group D3.Conclusion:For elderly patients with painless colonoscopy examination, compared with the simple intravenous application of propofol, preoperative15 min in the combination of 1.5 μg/kg dose DEX by nasal drug delivery, sedative effect is better, more stable hemodynamics in patients with simple operation, low incidence of adverse reactions, as a safe and ideal anesthetic scheme, is worth of popularization and application in clinical.